Logo Logo Logo Logo Logo
  • Know us
    • Our history
    • Key figures
    • Our values
    • Interview with the founders
  • Research
    • Clinical development
    • Pipeline
    • Research Centre
  • Diseases
    • Sleep apnoea and excessive daytime sleepiness
    • Anaphylactic shock
    • Diarrhoea
    • Narcolepsy
  • Products
    • ANAPEN®
    • CLASTOBAN®
    • CLEVIPREX®
    • FANOLYTE®
    • HELICOBACTER TEST INFAI
    • KENGREXAL®
    • OZAWADE®
    • REMODULIN®
    • TIORFAN®
    • TIORFANOR®
    • WAKIX®
  • News
  • Contact-us
  • Join us
  • Français
  • Know us
    • Our history
    • Key figures
    • Our values
    • Interview with the founders
  • Research
    • Clinical development
    • Pipeline
    • Research Centre
  • Diseases
    • Sleep apnoea and excessive daytime sleepiness
    • Anaphylactic shock
    • Diarrhoea
    • Narcolepsy
  • Products
    • ANAPEN®
    • CLASTOBAN®
    • CLEVIPREX®
    • FANOLYTE®
    • HELICOBACTER TEST INFAI
    • KENGREXAL®
    • OZAWADE®
    • REMODULIN®
    • TIORFAN®
    • TIORFANOR®
    • WAKIX®
  • News
  • Contact-us
  • Join us
  • Français
 

Sitemap

  • Confidentiality policy & cookies
  • Contact-us
  • Diseases
    • Anaphylactic shock
    • Diarrhoea
    • Narcolepsy
    • Sleep apnoea and excessive daytime sleepiness
  • Homepage
  • Know us
    • Interview with the founders
    • Key figures
    • Our history
    • Our values
  • Legal terms and conditions
  • News
  • Our commitments
  • Research
    • Clinical development
    • Pipeline
    • Research Centre
  • Sitemap
  • Transparency
  • Vacancies
  • ANAPEN®
  • CLASTOBAN®
  • CLEVIPREX®
  • FANOLYTE®
  • HELICOBACTER TEST INFAI
  • KENGREXAL®
  • OZAWADE®
  • REMODULIN®
  • TIORFAN®
  • TIORFANOR®
  • WAKIX®

Bioprojet PHARMA
9, Rue Rameau
75002 Paris
FRANCE
Useful links
  • Confidentiality policy & cookies
  • Legal terms and conditions
  • Our commitments
  • Transparency
  • Sitemap
 
Immediately report any adverse effect suspected of being due to a drug to your Regional Pharmacovigilance Center (CRPV) or on signalement.social-sante.gouv.fr

This site is intended for residents of France
Updated on 06/17/2022
Copyright © 2021-2022 BIOPROJET. All rights reserved